US Customs Ruling (CROSS)
 HS Code : | | |
|---|
 HTS Code : | | |
|---|
| CAS Number : | |
|---|
Ruling Number :
Issuing Country : UNITED STATES
Date Of Issue : 2018-11-07T00:00:00
Brazikumab (MEDI2070) and Brazikumab (AMG 139 MEDI2070) (CAS No. 1610353-18-8) in dosage form
The tariff classification of Brazikumab (MEDI2070) and Brazikumab (AMG 139 MEDI2070) (CAS No. 1610353-18-8) in dosage form, from the United States and imported from Ireland.
Brazikumab (MEDI2070) (INN) is a human monoclonal antibody designed for the treatment of Crohn's disease. Brazikumab (AMG 139, MEDI2070) is a fully human anti-IL23A monoclonal antibody in clinical development for autoimmune indications. In a follow-up email to this office, you stated Brazikumab will be imported in measured dosage form put up in pre-filled glass syringes.
Description : Brazikumab and Brazikumab in dosage form, from the United States and imported
Please importantly note that only the relevant portion of the related US Ruling (Cross) is displayed above. You may refer to the said customs ruling for the entire ruling explanation.
Source : US Customs Ruling (CROSS)
source link :